Skip to main content

Hearing Preservation on Gentamicin Treatment for Meniere’s Disease

  • Chapter
Hearing Impairment

Abstract

Meniere’s disease is characterized by episodic vertigo, fluctuating hearing loss, ear fullness and tinnitus. It may be due to increased pressure in one of the inner ear fluid compartments. Fluid in the inner ear chambers are constantly being produced and absorbed by the circulatory system. Any disturbance in this delicate relationship results in over-production or under-absorption of the fluids. This leads to increased fluid pressure (hydrops) that in turn produces dizziness which is often associated with fluctuating hearing loss and tinnitus. Endolymphatic hydrops is generally accepted as the histopathological finding for Meniere’s disease. However, pathophysiology of Meniere’s disease is still controversial.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Schuknecht HF (1957) Ablation therapy in the management of Meniere’s disease. Acta Otolaryngol (Stockh) 132: 3–42

    Google Scholar 

  2. Kaasinen S, Pyykkó I, Ishizaki H, Aalto H (1998) Intratympanic gentamicin in Meniere’s disease. Acta Otolaryngol (Stockh) 118: 294–298

    Article  CAS  Google Scholar 

  3. Driscoll CLW, Kasperbauer JL, Facer GW, Harner SG, Beatty CW (1997) Low-dose intratympanic gentamicin and the treatment of Meniere’s disease: preliminary results. Laryngoscope 107: 83–89

    Article  PubMed  CAS  Google Scholar 

  4. Ödkvist LM, Berbenius J, Lundgen A (1984) Topical gentamicin treatment for disabling Meniere’s disease. Acta Otolaryngol Suppl (Stockh) 412: 74–76

    Google Scholar 

  5. Kaasinen S, Pyykkö I, Ishizaki H, Aalto H (1995) Effect of intratympanically administered gentamicin on hearing and tinnitus in Meniere’s disease. Acta Otolaryngol (Stockh) Suppl 520: 184–185

    Article  Google Scholar 

  6. Magnusson M, Padoan S (1991) Delayed onset of ototoxic effects of gentamicin in treatment of Meniere’s disease. Acta Otolaryngol (Stockh) 111: 671–676

    Article  CAS  Google Scholar 

  7. Aran JM (1995) Current perspective on inner ear toxicity. Otolaryngol Head Neck Surg 112: 133–144

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Tokyo

About this chapter

Cite this chapter

Ishizaki, H., Pyykkö, I. (2004). Hearing Preservation on Gentamicin Treatment for Meniere’s Disease. In: Suzuki, JI., Kobayashi, T., Koga, K. (eds) Hearing Impairment. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68397-1_71

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68397-1_71

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-22326-9

  • Online ISBN: 978-4-431-68397-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics